"This is my 4th CfPIE course and I continue to be impressed by the knowledgeable speakers and the quality of the materials provided. Also the speaker is always open to follow up questions."
Gillian W., Compliance Specialist, Allergan
"This was a fabulous program! The instructor was incredibly knowledgeable. This course will help me so much in my job."
Robin H., Manager, Quality Assurance, Baxter Healthcare
"Outstanding course! Outstanding instructor! It is refreshing to attend professional training and receive it from a superior subject matter expert. I would definitely recommend this course and would enjoy taking another course from this Course Director."
David H., QA/QC Director, Hill-Rom
"Speaker was engaging and very knowledgeable about discussion topics. He was able to go off script, tie back into course fabric without disruption. Very impressive."
Ryan D., Product Manager - Marketing, Covidien
This course is being offered on an as-requested basis. Please join the wait list or request on-site delivery details.
The course will cover drug marketing and promotional issues specific to brand-name (prescription and OTC), generic, and compounding pharmacy contexts, including such areas which are "in flux" as Continuing Medical Education, Advertising of Compounding Products, Off-Label Promotion, Gifts to Physicians, and Direct-to-Consumer Advertising. Advertisements and case studies, including notable enforcement actions by the FDA and FTC will be discussed. Additionally, case law will be examined in detail, including strategies for staying under the "regulatory radar" and developing an effective in-house promotional review system.
This drug marketing and medical device advertising course provides a comprehensive description of the various regulatory and legal standards and their specific application to the advertising and promotion of drug and medical device products including detailed analysis of advertisements and promotion. These include regulations and policies of the FDA, FTC, DEA, PHS, Office of the Inspector General (OIG), state attorneys general and prosecutors, and professional guidelines of relevant organizations including ACCME, ACP, PhRMA and the AMA.
Pharmaceutical & medical device advertising course participants will receive resource materials including:
This pharmaceutical marketing training course will provide attendees with a better understanding of responsibilities in the areas mentioned above. Additionally, participants will gain a greater knowledge of the issues faced which can affect common marketing and promotional activities.
This 15 hour pharmaceutical marketing training course was developed to assist personnel who have varying levels of experience in drug and device advertising, marketing and promotion. It is intended for those involved with:
Attendees will have the opportunity to consult with the instructor during breaks and after hours on specific issues. The pharmaceutical marketing training Course Director has over twenty-five years experience as a food and drug attorney with extensive involvement in drug marketing and advertising issues both in private practice, in-house for a multi-national pharmaceutical company, with direct interaction with the FDA and FTC.
Upon completion of this course, participants will have an excellent understanding of the laws and policies affecting advertising, marketing and promotion, and the manner of their application in practice. Attendees will be better able to develop marketing and advertising programs and avoid issues which regulatory agencies continually review.
Regulatory affairs professionals and attorneys will receive training in the applicable laws, regulations and agency policies and gain practical knowledge of how to detect and analyze pitfalls in dealing with the review process. Participants will also gain an understanding of how third parties, such as the FDA, the FTC - and even the courts – currently view advertising and marketing issues. An increased awareness of the disparate roles of various corporate departments in the development of advertising and promotion and strategies for their interaction/cooperation is also an important goal of the course.
"Overall, excellent course! Instructor was very experienced and knowledgeable."
Jonn W., Director, US Medical Affairs
"This is my 4th CfPIE course and I continue to be impressed by the knowledgeable speakers and the quality of the materials provided. Also the speaker is always open to follow up questions."
Gillian W., Compliance Specialist, Allergan
"Speaker was engaging and very knowledgeable about discussion topics. He was able to go off script, tie back into course fabric without disruption. Very impressive."
Ryan D., Product Manager - Marketing, Covidien
"The course director is extremely knowledgeable to the subject matter. In addition his presentation style is interesting and engaging. I found the course to be very well stimulated and informative. I would highly recommend the course to others in my company."
Tina C., VP Commercialization, EOS
"This was a fabulous program! The instructor was incredibly knowledgeable. This course will help me so much in my job."
Robin H., Manager, Quality Assurance, Baxter Healthcare
"Great class! I gained so much more knowledge on the details and history of the regulations and guidelines than just reading them."
Ellen S., Sr. Corporate Compliance Auditor, Abbott
"Outstanding course! Outstanding instructor! It is refreshing to attend professional training and receive it from a superior subject matter expert. I would definitely recommend this course and would enjoy taking another course from this Course Director."
David H., QA/QC Director, Hill-Rom
Session 1: Introduction
Advertising and Promotion Regulation Overview
Session 2: The Laws Governing Advertising and Promotion: FDA
The Role of the Federal Trade Commission
Other Agencies
Session 3: In-Depth Analysis of Requirements for Advertising and Promotion
Session 4: Anatomy of a Drug Ad
Session 5: Specific Issues in Drug Promotion and Advertising
Off-Label Promotion
Medical Education
Session 6: Other Communications and Promotion
FDA and FTC Enforcement
Session 7: New FDA Initiatives and Special Situations
Session 8: In-depth analysis of FDA Warning Letters
Current Hot Topics in Advertising and Promotion
Questions and Answers
Absolutely. Regulation of marketing and promotion is a highly dynamic area both on the Federal and State levels. This course will cover the most significant and up to date developments in such areas as social media, the internet, electronic communications, and reporting of gifts to physicians.
Yes. This course provides both the underlying legal and regulatory framework as well as practical examples taken from FDA warning letters and other enforcement action so that the participant can understand the conceptual underpinnings of the regulations, and know their practical application in FDA's enforcement actions.
The format of the course combines instruction by the instructor as well as class discussion of case studies. Class participation is encouraged, to take advantage of the different experiences and practices of the different companies represented in the class.
The instructor remains available for questions and follow-up via telephone and email on any topics covered in the course, in case the attendees require further explanation, or if something comes up in their work on which they would like further guidance.
Registrant Information:
Each person attending a course will be asked to set up an Attendee Profile Account during the registration process. Creating an Account helps you view your order history and manage your training programs. If you are registering for others, please set up an Account in the Attendee’s name. If you are registering more than one person, you’ll need to set up a separate account for each Attendee.
Since 2001 CfPIE has
Need help finding the right life sciences training courses? We can help you make the right choice based on your company's needs.
All Rights Reserved | CfPIE Inc. | Our courses and materials are copyrighted by CfPIE, Inc. and may not be used or reproduced without the written permission of CfPIE, Inc. management. | In partnership with CCC